Regulation of whole-body metabolism and energy homeostasis has been shown to require signaling between multiple organs. To identify genetic programs that determine metabolic rate, and compounds that can modify it, a whole-animal assay amenable to large-scale screening was developed. The direct correlation of acid production with metabolic rate was exploited to use a noninvasive colorimetric assay for acid secretion by individual zebrafish larvae in a 96-well plate format. A 3-fold increase in metabolic rate was detected that accompanied development between 24 and 96 h postfertilization. Dynamic changes in metabolic rate were also detected in response to different conditions such as temperature and drug treatments, in general agreement with the rate of oxygen consumption measured concomitantly. This assay was used to measure metabolic rate in the progeny of fish known to carry a recessive mutation in a gene required for ribosome biogenesis (npo fW07-g ), which would be expected to reduce energy consumption. A strong correlation was found (p < 10 -6 ) between reduced metabolic rate and genotype even before the developmental defect was visually evident. These studies support the conclusion that wholeanimal acid secretion can be used as a readout for energy metabolism, thus enabling large-scale screening for genetic and chemical regulators of metabolic rate in a vertebrate. (Journal of Biomolecular Screening 2008;960-967) 
INTRODUCTION

E
NERGY IMBALANCE underlies many of the most common diseases in Western society, such as obesity, cardiovascular disease, and diabetes. A common thread linking these conditions is a mismatch between caloric intake and expenditure. This mismatch sets in motion a cascade of downstream events such as the accumulation of lipid in blood vessels, liver, and adipose tissue, and the deregulation of glucose metabolism. Understanding the molecular network mediating energy balance is therefore of critical importance to preventing and treating such diseases before they cause end-organ damage.
Genetic studies in model animals and humans are beginning to reveal the molecular underpinning of energy homeostasis, largely stemming from a combination of forward and reverse genetics in the mouse, as well as genetic mapping and whole-genome analysis in humans. 1, 2 In this context, energy intake is the most commonly used readout, as is net calorie balance. In contrast, energy expenditure has received relatively less attention. One reason may be the inherent difficulty in measuring an animal's metabolic rate, which is typically performed by indirect calorimetry. This method involves confining a person or model organism to a sealed chamber while measuring O 2 consumption and CO 2 production. Although useful for small sample numbers, it is not feasible for the large number of measurements required to perform a largescale chemical or genetic screen. A plate assay for measuring metabolic rate in cultured cells has been developed recently, 3 but this approach is not immediately adaptable to whole animals. Assays for metabolic phenotypes in model organisms have been reported using established invertebrates such as Drosophila and Caenorhabditis elegans. In these cases, the readouts are visually discernible outcomes such as fat accumulation. 4, 5 However, these invertebrates lack direct orthologs of the vertebrate organs known to be critical for metabolic regulation, such as the hypothalamus, liver, pancreas, intestine, and thyroid. To enable large-scale measurements of metabolism in a vertebrate, we designed a wholeanimal microassay using the zebrafish.
The zebrafish is a vertebrate model with many attributes of invertebrate model organisms (see Lieschke and Currie 6 for a review). Like invertebrates, they develop externally to the mother and produce a large number of offspring in 1 mating (>100), but they have prototypical vertebrate organs that begin to function even before 2 d postfertilization (dpf). Although zebrafish have been used mostly as a developmental model system, they can also be used to study physiological processes such as heart rate control, lipid homeostasis, and glucose uptake. [7] [8] [9] Here we describe an assay to enable large-scale screening for chemical and genetic modifiers of metabolic rate in an intact vertebrate. As such, the assay can be used upstream of secondary assays that measure specific metabolites and pathways.
MATERIALS AND METHODS
Fish stocks
The zebrafish TuAB strain was used for the majority of the study. Zebrafish stocks were raised and maintained as described previously. 10 Embryos were raised in egg medium without phenyl-2-thiourea to prevent any possible side effects on metabolic rate. The nil per os (npo fw07-g ) mutant was previously identified and characterized.
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Drug treatment
Stock solutions of rapamycin (Sigma, St. Louis, MO) and isoproterenol were prepared in DMSO and added to the embryo medium at the indicated concentrations and times prior to the assay. 2,4-dinitrophenol (DNP; MP Biomedicals, Irvine, CA) was made as a 0.25-M stock solution in methanol.
Colorimetric assay
The assay was performed using 72 hpf larvae unless stated otherwise. The assay medium consists of reverse osmosispurified water with added mineral salts (Kent R/O Right; Aquatic Habitats, Apopka, FL) to achieve a conductivity of 350 μS at 25 °C. The pH of the water is then adjusted to pH 8.0 with a concentrated sodium bicarbonate solution, and phenol red is added to a final concentration of 0.01% (w/v). The larvae are rinsed 3 times with 10 mL of assay medium and then transferred into wells of a 96-well bottom plate in 50 μL assay media. We have used round-bottom and flat-bottom plates, each of which display different absorbance characteristics such that a standard curve for each well type is needed. The wells are then overlaid with 100 μL mineral oil to control gas exchange with the surrounding environment. The phenol red absorbance at 570 nm is then measured at 10-min intervals for 1 h, unless stated differently, using a μQuant Microplate Spectrophotometer (BioTek Instruments, Winooski, VT) and KC4 Kineticalc for Microsoft Windows software version 2.5 (Bio-Tek Instruments).
To relate the absorbance of phenol red to acid production, we generated an empiric titration curve by adding known amounts of acid to 50 μL of assay medium and measured absorbance at 570 nm. We fitted the data to a modified Henderson-Hasselbach equation using a nonlinear least-squares fitting algorithm (DeltaGraph). The curve in Figure 1C was calculated using the following equation:
We found that using round-bottom versus flat-bottom plates gave different parameters for the titration curve. For roundbottom plates, calculated parameters were K = 1.44 × 10 -8 moles, A 570(max) = 2.0, A 570(min) = -0.33, correlation coefficient R 2 = 0.980. For flat-bottom plates, the parameters were K = 1.38 × 10 -8 , A 570(max) = 0.39, A 570(min) = -0.55. We used this equation to convert A 570 to moles of acid produced, as shown in Figure 1D . We calculated the rate of acid production by plotting moles of acid produced versus time and determining the slope by linear regression (Microsoft Excel). We determined the correlation coefficient for the time courses and excluded samples with values less than 0.9. In all cases, we performed more than 12 independent, simultaneous measurements per condition and repeated the experiments at least once. After determining the acid production rate, we calculated the average and standard deviation and performed a 2-tailed t-test to determine statistical significance (Microsoft Excel). For the data shown in Figure 2 , sample distribution analysis for both wild-type and mutant was performed using SAS version 9.0.
Automated embryo sorting
Zebrafish embryos at 72 hpf were sorted by a COPAS™ (Complex Object Parametric Analyzer and Sorter) Instrument (Union Biometrica, Holliston, MA). Embryos were enriched by electronically gating on time of flight and extinction, dictated by axial length and optical density of the embryo, respectively. Assay medium (composition discussed above) was used in both sample and sheath fluid for sorting embryos.
Gas measurements
To measure oxygen consumption, 20 embryos were confined to 1 mL of medium, giving a density comparable to the microplate assay (50 μL/embryo). Samples were withdrawn at 30-min intervals using 125-μL Clinitubes capillaries (D957G-70-125, Radiometer Copenhagen, Denmark), and pO 2 measurements were taken using an ABL 725 Radiometer Analyzer (Radiometer Copenhagen).
DNA extraction and genotyping
DNA was extracted from individual embryos at 72 hpf after the colorimetric assay in the 96-well plate. Proteinase K was added to each well to a final concentration of 0.7 μg/mL in lysis , yielding a linear time course over a 1-h interval. The acid production rate was determined by linear regression. (E) Larvae (80 hpf) in assay medium were manually introduced into 94 wells of a 96-well plate, and A 570 was measured at 10-min intervals over 1 h. The calculated assay production rates are plotted as a function of well number (A1, A2, . . . , B1, B2, etc.). The solid line represents the mean (3.1 × 10 -10 ± 0.8 mole/min/embryo [mean ± SD, n = 84]), and the dotted lines indicate 2 standard deviations from the mean. (F) Using an automated large-particle sorter, we introduced embryos into alternating rows of the assay plate, leaving only assay medium in the intervening rows. Acid production rates were measured and plotted as in panel E. The red squares represent wells without embryos. The mean rate was 2.7 × 10 -10 ± 0.7 (mean ± SD, n = 40), and the distribution of rates was random with respect to well position.
buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.3% Tween-20, 0.3% Nonidet P40), and the plate was incubated overnight at 50 °C. The proteinase K was heat killed at 95 °C for 5 min. The extracted DNA was used at a 1:50 dilution for PCR. For genotyping, we performed allele-specific PCR to discriminate homozygous wild-type, heterozygous, and homozygous mutant genotypes. Each reaction uses a set of 3 primers: 2 flanking the mutation and 1 internal allele-specific primer to obtain a larger (control) product and a smaller (allele-specific) product, as illustrated in Figure 2 .
Primer sequences for the 320 bp fragment were as follows:
forward primer: TCG AGA AAG TAG GTC AAA TTA GCA reverse primer: CTG GCC TAG TGC TTT TCT GG.
For the 180-bp fragment:
wild-type reverse primer: CAC CAT TTT GGA GCG GAG A mutant reverse primer: CAC CAT TTT GGA GCG GAG T
FIG. 2.
Genotype-phenotype correlation using metabolic rate assay. (A) The progeny of TuAB (top) and TuAB/npo fw07-g (bottom) intercrosses were analyzed for acid production at 72 hpf, a stage prior to the onset of a clear visual phenotype in the homozygous mutant fish. 11 Histograms show the rate distributions from the 2 clutches. The mutant in-cross yielded a clutch whose rate distribution is wider and centered to the left of the control, as reflected by a lower mean and standard deviation. Postassay analysis allowed assignment of a genotype to each embryo, as indicated by the bar shading. Genotypes are indicated as follows: +/+, homozygous wild-type; +/-, heterozygous; -/-, homozygous mutant. There was no significant difference in rates between +/+ and +/-; hence, these rates were aggregated for comparison to -/-. (B) Genotyping with allelespecific PCR. The 320-bp product is an allele-independent positive control for the efficiency of the PCR. The internal allele-specific reverse primer amplifies either the wild-type (left) or mutant allele (right). Because the genome is diploid, both wild-type and mutant primer sets are required to unambiguously determine an embryo's genotype. (C) The metabolic rate of the homozygous larvae was significantly lower than the wild-type or the heterozygous larvae (bar graphs depict mean ± SD, n = 36 for +/+ and +/-, n = 12 for -/-, *p < 0.05).
The PCR program was the following: 94 °C for 3 min, 94 °C for 30 s, 58 °C for 30 s, 72 °C for 1 min, 34 cycles between steps 2 and 4, 72 °C for 10 min, 4 °C for ∞.
The products were then resolved on a 2% agarose gel.
RESULTS
Assay conditions
Acid is the end product of both aerobic and anaerobic metabolism. Aerobic metabolism produces CO 2 as the final product, which produces carbonic acid upon hydration, and anaerobic metabolism yields lactic acid. Thus, in a closed system, acid accumulation in the immediate environment will reflect the aggregate metabolic rate of the whole animal. In principle, confining zebrafish larvae to a small volume with a pH-sensitive indicator dye should enable continuous monitoring of acid production via absorbance. However, we did not know if the amount of acid produced over a relatively short interval (i.e., 1 h) would be easily detectable.
Phenol red is a well-established nontoxic pH indicator with a pK (7.4) at physiological pH. Using the known chemical and spectral properties of phenol red, we empirically determined its optimal concentration, wavelength, and pH for measuring absorbance changes in microplate wells. By systematically varying these parameters, we found that 50 μL of a 0.01% (w/v) phenol red solution provided the best dynamic range for measuring absorbance changes. Next, we found that our aquaculture system water (see the Materials and Methods section) titrated to pH 8.0 with sodium bicarbonate provided the best starting conditions. The larvae survived with no ill effects when kept at least 2 days under these conditions. Figure 1A shows that 50 μL of medium accommodates the embryo easily, and medium acidification during a 1-h incubation can be appreciated visually by the color change from red to orange. Panel B shows a time course for A 570 over this interval, yielding absorbance changes easily measurable with a plate reader (from 1.2 to 0.6). Using a standard curve to empirically determine the relationship between A 570 and acid production (Fig.  1C and the Materials and Methods section), we converted A 570 to H + produced and found that the time course for acid production was linear over 1 h (Fig. 1D) . Thereafter, to calculate the acid production rate, we used a simple linear regression model to determine the rate of acid production in moles H + per minute. To assess well-to-well variation, we measured metabolic rates in a full 96-well plate (Fig. 1E) . The measured rates were scattered around the mean randomly with no detectable bias toward peripheral or internal wells. We also compared manual versus automated sorting into a 96-well plate using a COPAS large particle sorter. Figure 1F shows that embryos introduced into alternate rows by automated sorting gave a similar rate distribution as those manually introduced into the entire plate.
Empty wells yielded acid production rates near zero, providing a high signal-to-background ratio.
Genetic perturbation of metabolic rate
To test the ability of the assay as a screening tool for mutations that alter the whole-animal metabolic rate, we used the npo fWO7-g mutant. In particular, we wanted to discriminate a mutant from a wild-type clutch of larvae without prior knowledge of embryo genotype. The mutation encodes a truncation of an essential nucleolar protein (RBM19), thus impairing ribosome biogenesis and arresting growth of the digestive organs in the homozygote mutants at about 96 hpf. 11 We crossed npo heterozygote adults to generate clutches of embryos with the expected Mendelian ratios (+/+, +/-, -/-, in a ratio of 1:2:1, respectively) and measured the rates in parallel to a control wild-type clutch. We took a random sampling of 36 embryos from each clutch for the assay, followed by individual embryo genotyping. We then generated histograms to visualize the metabolic rate distribution (Fig. 2) . The wild-type larvae had a mean rate of 15 ± 2.7 × 10 -11 moles/min, whereas the heterozygote in-cross progeny had a mean of 10 × 10 -11 ± 3.1 moles/min ( Fig. 2A) . The data suggest that, without prior knowledge of the parents' genotype, we can discriminate a wild-type from a mutant clutch based on the acid production rate.
After completing the assay, we performed an in-plate lysis to extract the DNA for genotyping. Allele-specific PCR enabled unambiguous correlation of genotype with phenotype (Fig. 2B) . The homozygous mutants were biased to the left portion of the distribution curve, whereas the homozygous wild-type and heterozygote mutants distributed similarly to the control mating shown in the top panel ( Fig. 2A) . The disparity between mutant and wild-type acid production rates is best seen when calculating the mean for each genotype (Fig. 2C) , with the homozygous mutant rate nearly one-half that of the wild type.
Variation of metabolic rate with stage
During development, cell number increases dramatically as the embryo grows, and the aggregate metabolic rate of the organism would be expected to increase proportionally. We used this assay to monitor the metabolic rate as a function of developmental stage and detected the expected increase (Fig.  3A) . We noted a roughly 25% increase in the rate of acid production between 24 and 48 hpf and then a 60% increase between 48 and 72 hpf, consistent with the rapid growth phase expected after formation of organ primordia.
Zebrafish are poikilothermic organisms, adopting the temperature of their environment. As such, their rate of development can be modulated by temperature, indicating that metabolic rate would vary with temperature as well. We raised embryos at the standard temperature of 28.4 °C and then performed the assay at 25 °C and 32 °C. The increase in temperature resulted in a 2-fold increase in the acid production rate (Fig. 3B) . This further supports the idea that the measured acid production rate is a valid readout of metabolic rate.
Variation of metabolic rate in response to drug treatment
One of the applications of this assay will be to screen compounds for their effect on metabolic rate. To test the viability of this approach, we assayed the effects of 2 compounds known to either inhibit or accelerate metabolism. Rapamycin is a specific inhibitor of the target of rapamycin (TOR), which controls cell growth and division. 12 In many model systems, the effect of rapamycin is similar to the effect of amino acid starvation, which is to shift cells from an anabolic to a catabolic state, resulting in a decrease in the metabolic rate as energy conservation pathways are activated. Consistent with this mode of action, treatment with rapamycin inhibited acid production in zebrafish (Fig. 4A and B) . We performed the experiment using 2 different larval stages and found that rapamycin inhibited acid production more potently in 72 hpf than in 48 hpf. This difference may reflect increased dependence on TOR for growth control at the later stage, as suggested previously. 13 DNP uncouples oxidative phosphorylation by dissipating the proton gradient across the inner mitochondrial membrane. This perturbation results in a higher rate of carbon oxidation to produce a given amount of ATP. Accordingly, we expected that treatment of zebrafish embryos with DNP would result in an increase in the acid production rate. We observed a dosedependent rate increase of up to 60% relative to control with 50 μM DNP (Fig. 4C) . At higher doses, we encountered toxicity and death.
The effect of drug treatment on metabolic rate was also evaluated by measuring oxygen consumption. Consistently, there was a significant decrease in oxygen consumption with rapamycin and an increase with DNP treatment (Fig. 4D) .
We also tested 6 dpf embryos for the effect of isoproterenol and found an increased acid production rate of 10% above controls, which is comparable to the heart rate change previously reported.
14 However, in our assay, the effect was not statistically significant (p > 0.05) likely because of the inherent variation of metabolic rate among embryos, as discussed below.
DISCUSSION
Diseases such as obesity that result from energy imbalance are on the rise in Western societies. Pharmacological treatment and prevention will require an understanding of the genetic basis of energy homeostasis. 15 Testing drugs or identifying genes that regulate metabolic rate will require a whole-animal model, because metabolism is controlled at the systemic level rather than being localized to 1 specific cell or tissue.
Here we report the development of a novel whole-animal assay for metabolic rate. To our knowledge, this is the 1st assay that offers a readout of metabolic rate in an intact vertebrate that is amenable to large-scale screening. Using acid production as a proxy measurement for CO 2 and lactic acid, we show that this parameter varies as predicted for developmental age, temperature, genotype, and small-molecule treatment. Notably, the assay does not damage the organism, enabling secondary assays on the same embryos and genotyping by allele-specific PCR. We demonstrated that the assay can detect the effect of a mutation on metabolic rate before the onset of a visual phenotype.
FIG. 3.
Acid production rate varies with age and ambient temperature. (A) Zebrafish embryos at the indicated stages of development were used in the assay. The rate of acid production was calculated as described in the Materials and Methods section. As expected, the acid production increased with embryonic development. (B) Increased temperature results in a codirectional increase in the larval metabolic rate as reflected in the bar graph. (Bar graphs show mean ± SD, n = 12, *p < 0.05).
This will enable genetic mapping of quantitative trait loci that encode modifiers of metabolic rate. In addition, we anticipate its application to screen large small-molecule libraries for compounds that modulate metabolic rate.
Many of the problems we anticipated did not materialize in practice. We were concerned that the quantity of acid produced by a single embryo might not be adequate to alter the ambient pH to be detectable by a plate reader. In practice, a 1-h incubation resulted in a change in A 570 of >1.0 units. A 2nd concern was toxicity from waste products concentrating in the small volume of medium to which the animal is confined.
This seems unlikely to be a problem because the period of confinement is brief (totaling about 90 min) and the pH remains greater than 7.0, based on direct blood gas measurements (not shown). The animals do not seem to be compromised because they remain viable in the wells for at least 48 h after the monitoring period. Direct measurements of oxygen levels show that during the 1-h monitoring interval, oxygen tensions typically do not fall below 100 mm Hg (Fig. 4) . If subtle effects do occur as a result of these assay conditions, they will likely affect all the embryos similarly and should cancel each other out. Finally, there is a precedent for confining zebrafish   FIG. 4 . The effect of drug treatments on larvae metabolic rate. Rapamycin was added to embryos 24 h before the respective assays. At 48 hpf (A) and 72 hpf (B), the larvae were confined to the assay wells. Rapamycin treatment results in a significant decrease in the metabolic rate (*p < 0.05) at 72 hpf. (C) 72 hpf embryos were treated with 2,4 dinitrophenol (DNP) at indicated concentrations for 1.5 h prior to confinement in the assay well. Data indicate an increase in the metabolic rate with 2,4 DNP treatment in a dose-dependent manner (*p < 0.05). (D) Oxygen consumption in response to drug treatment. Consistent with the colorimetric assay, oxygen consumption was increased with 2,4 DNP and decreased with rapamycin treatment compared with the control group. Bar graphs depict mean± SD, n = 12.
to a finite volume for the purpose of measuring metabolic rate. Previous studies have measured CO 2 production and O 2 consumption in confined larvae with few adverse effects noted. [16] [17] [18] We noted that the mean acid production rates typically fall into a normal distribution, with standard deviation of about 25% of the mean. This ratio does not change substantially under different conditions such as different well shapes, plate readers, or the number of embryos assayed. Therefore, this likely represents the inherent variation in metabolism between animals. One explanation may be that zebrafish strains (such as TuAB used in this study) are not inbred and may harbor polymorphisms that contribute to a variable metabolic rate phenotype. Alternately, the developmental rate within a clutch may vary between animals. Regardless, the implication for designing a large-scale screen is that multiple embryos will be needed to detect modest differences between genotypes or compounds. For example, treating about 12 embryos will be necessary to detect a 30% increase in metabolic rate with a confidence of greater than 95% (p < 0.05). This constraint is readily surmountable for a dedicated screening facility. Large numbers of zebrafish embryos (thousands per day) can be generated by a relatively small aquaculture facility dedicated to this purpose (approximately 600 square feet). In addition, automation of embryo sorting, metabolic rate measurements, and data analysis can be accomplished with existing technologies.
Because the assay is rapid and noninvasive, information derived from particular embryos can be used to guide downstream analyses, such as genotyping, gene expression analysis, or secondary assays for particular metabolites. These could include any assay currently performed on zebrafish embryos, such as whole mount in situ hybridization, immunostaining, or monitoring GFP expression if organ-specific transgenic fish are used. Fish with particular metabolic phenotypes can also be raised and scored at later stages, depending on survival. Finally, this assay has the potential to be used with older larvae or young fish by simply adapting to a higher volume and larger well size. In summary, the assay described here may enable approaches not previously feasible to studying energy homeostasis in vertebrates, such as largescale genetic or small-molecule screens.
